Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Change in Inventory (2023 - 2025)

Bioregenx's Change in Inventory history spans 3 years, with the latest figure at -$2447.0 for Q4 2025.

  • Quarterly results put Change in Inventory at -$2447.0 for Q4 2025, up 94.86% from a year ago — trailing twelve months through Dec 2025 was -$4163.0 (up 96.09% YoY), and the annual figure for FY2025 was -$4163.0, up 96.09%.
  • Change in Inventory for Q4 2025 was -$2447.0 at Bioregenx, up from -$24852.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $140156.0 in Q1 2023 to a low of -$79245.0 in Q3 2023.
  • The 3-year median for Change in Inventory is -$5197.0 (2024), against an average of -$6197.1.
  • Peak annual rise in Change in Inventory hit 801.0% in 2025, while the deepest fall reached 267.9% in 2025.
  • Year by year, Change in Inventory stood at $38645.0 in 2023, then tumbled by 223.26% to -$47632.0 in 2024, then surged by 94.86% to -$2447.0 in 2025.
  • According to Business Quant data, Change in Inventory over the past three periods came in at -$2447.0, -$24852.0, and -$6208.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.